GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. Is Hims & Hers ...

Here's a wrap-up of news on medicines and clinical treatments, including a win for the AMA, and updates from the TGA, PBS, and MBS, as well as ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

Since then, I’ve tried virtually everything I offer my patients: I inject Profhilo every few weeks, have Botox every two or three months, inject polynucleotides, which plump up fine skin, three times ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

At least 1 in 5 women older than 50 in the U.S. have osteoporosis, but many don’t realize it. How strong are your bones?

Veterinary toxicologists are warning clients about the dangers of accidental exposure to semaglutide weight loss medications ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

Leicester is the weight loss injection capital with almost 2,000 drugs prescribed each month, 6.8 times the proportion dished ...